GENOME RESEARCH LTD. - United Kingdom 

Ranking results:

Past rankings:

2020
Criterium:Position:
Overall Score:700-800
Total Project Funding per Partner:700-800
Total Number of Projects:600-700
2018
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Networking Rank (Reputation):600-700
2016
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2015
Criterium:Position:
Overall Score:700-800
Total Project Funding per Partner:600-700
Total Number of Projects:600-700
Networking Rank (Reputation):> 1000
Partner Constancy:700-800
Project Leadership Index:700-800
2014
Criterium:Position:
Overall Score:300-400
Total Project Funding per Partner:300-400
Total Number of Projects:300-400
Networking Rank (Reputation):700-800
Partner Constancy:100-200
Project Leadership Index:200-300
Diversity Index:200-300
2013
Criterium:Position:
Overall Score:500-600
Total Project Funding per Partner:100-200
Total Number of Projects:68
Total Project Funding:200-300
Partner Constancy:55
Project Leadership Index:69
Diversity Index:39
2012
Criterium:Position:
Overall Score:900-1000
Total Project Funding per Partner:400-500
Total Number of Projects:69
Total Project Funding:> 1000
Networking Rank (Reputation):> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:46
Project Leadership Index:75
Diversity Index:60
2011
Criterium:Position:
Overall Score:900-1000
Total Project Funding per Partner:200-300
Total Number of Projects:200-300
Total Project Funding:200-300
Networking Rank (Reputation):300-400
Partner Constancy:100-200
Project Leadership Index:> 1000
Diversity Index:> 1000
2010
Criterium:Position:
Overall Score:300-400
Total Project Funding per Partner:100-200
Total Number of Projects:300-400
Total Project Funding:92
Networking Rank (Reputation):300-400
Partner Constancy:19
Project Leadership Index:300-400
Diversity Index:> 1000
2009
Criterium:Position:
Overall Score:300-400
Total Project Funding per Partner:200-300
Total Number of Projects:300-400
Total Project Funding:200-300
Networking Rank (Reputation):500-600
Partner Constancy:100-200
Project Leadership Index:200-300
Diversity Index:> 1000
2008
Criterium:Position:
Overall Score:900-1000
Total Project Funding per Partner:300-400
Total Number of Projects:300-400
Total Project Funding:300-400
Networking Rank (Reputation):400-500
Partner Constancy:200-300
Project Leadership Index:> 1000
Diversity Index:> 1000
2007
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:200-300
Total Number of Projects:500-600
Total Project Funding:100-200
Networking Rank (Reputation):400-500
Partner Constancy:100-200
Project Leadership Index:> 1000
Diversity Index:> 1000

Ranking timeline:

Project Participation Performance(2010-01-01 - 2025-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 64
As coordinator: 5
As participant: 50
Sole participant: 9
Coordinator / Participant Ratio: 0.1*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2023 0 2.497.298 0 1
2022 0 17.080.738 0 1
2021 650.801 12.625.458 1.433.694 3 3
2020 224.934 20.615.447 2.452.166 1 4
2018 158.520 0 41.704 1
2017 0 50.265.292 821.174 4
2016 2.500.000 1.980.685 4.068.926 1 1
2015 183.455 39.343.192 1.864.508 1 6
2014 443.213 29.314.236 1.545.313 2 3
2013 221.606 68.432.780 8.501.293 1 5
2012 209.593 2.977.932 1.987.524 1 2
2011 390.696 71.611.949 6.073.430 2 10
2010 10.499.999 94.699.423 13.657.396 1 10
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
EUROPEAN MOLECULAR BIOLOGY LABORATORY20
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE15
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV11
MEDICAL RESEARCH COUNCIL11
GSF FORSCHUNGSZENTRUM FUER UMWELT UND GESUNDHEIT10
KAROLINSKA INSTITUTE9
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM8
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE8
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE8
UNIVERSITY COLLEGE LONDON8
CENTRE EUROPEEN DE RECHERCHE EN BIOLOGIE ET MEDECINE7
THE UNIVERSITY OF EDINBURGH7
UNIVERSITY OF HELSINKI7
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE6
STICHTING HET NEDERLANDS KANKER INSTITUUTANTONI VAN LEEUWENHOEK ZIEKENHUIS6
STICHTING KATHOLIEKE UNIVERSITEIT6
THE BABRAHAM INSTITUTE6
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD6
UNIVERSITY OF COPENHAGEN6
UPPSALA UNIVERSITET6
CHARITE UNIVERSITAETSMEDIZIN BERLIN5
COMMISSARIAT A L'ENERGIE ATOMIQUE5
CONSIGLIO NAZIONALE DELLE RICERCHE5
FUNDACIO PRIVADA PARC CIENTIFIC DE BARCELONA5
REGION HOVEDSTADEN5
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM4
ACADEMISCH ZIEKENHUIS GRONINGEN4
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS4
CANCER RESEARCH UK4
DANMARKS TEKNISKE UNIVERSITET4
KING'S COLLEGE LONDON4
LEIDEN UNIVERSITY MEDICAL CENTER4
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN4
TORONTO CENTRE FOR PHENOGENOMICS INC4
UNIVERSITAT AUTONOMA DE BARCELONA4
UNIVERSITE DE GENEVE4
USTAV MOLEKULARNI GENETIKY AKADEMIE VED CESKE REPUBLIKY VEREJNA VYSKUMNA INSTITUCE4
BAYER3
BAYER PHARMA3
CHRISTIANALBRECHTSUNIVERSITAET ZU KIEL3
FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH3
INSTITUT PASTEUR3
KONINKLIJKE NEDERLANDSE AKADEMIE VAN WETENSCHAPPEN KNAW3
KUNGLIGA TEKNISKA HOEGSKOLAN3
LUNDS UNIVERSITET3
MEDIZINISCHE UNIVERSITAET WIEN3
NOVARTIS FORSCHUNGSSTIFTUNG ZWEIGNIEDERLASSUNG FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH3
OSLO UNIVERSITETSSYKEHUS HF3
STATENS SERUM INSTITUT3
SYNOME3
TARTU ULIKOOL3
TECHNISCHE UNIVERSITAET DRESDEN3
TEL AVIV UNIVERSITY3
THE UNIVERSITY OF SHEFFIELD3
UNITED KINGDOM RESEARCH AND INNOVATION3
UNIVERSITAET ULM3
UNIVERSITAET ZUERICH3
UNIVERSITE DE LIEGE3
UNIVERSITY OF BOLOGNA3
UNIVERSITY OF CAMBRIDGE3
VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG3
WEIZMANN INSTITUTE OF SCIENCE3
ACADEMISCH ZIEKENHUIS LEIDEN2
AGENCE NATIONALE DE SECURITE SANITAIRE DE L'ALIMENTATION DE L'ENVIRONNEMENT ET DU TRAVAIL2
AGENCIA ESPANOLA DE MEDICAMENTOS Y PRODUCTOS SANITARIOS2
AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS2
ALBERT LUDWIGS UNIVERSITAET FREIBURG2
BIOMEDICAL SCIENCES RESEARCH CENTER ALEXANDER FLEMING2
BUNDESINSTITUT FUR ARZNEIMITTEL UND MEDIZINPRODUKTE2
CARTANA AB2
CELGENE MANAGEMENT SARL2
CELLZOME2
CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS2
CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER2
EUROPEAN GROUP FOR BLOOD AND MARROW TRANSPLANTATION2
EUROPEAN HEMATOLOGY ASSOCIATION2
EUROPEAN RESEARCH INITIATIVE ON CLL EV2
EXPRES2ION BIOTECHNOLOGIES APS2
FONDAZIONE ITALIANA SINDROMI MIELODISPLASTICHE ETS2
FRIEDRICH LOEFFLER INSTITUT BUNDESFORSCHUNGSINSTITUT FUER TIERGESUNDHEIT2
FUNDACAO CALOUSTE GULBENKIAN2
FUNDACIO CENTRE DE REGULACIO GENOMICA2
FUNDACIO INSTITUT DE RECERCA BIOMEDICA2
FUNDACIO INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS2
FUNDACIO PRIVADA CENTRE DE REGULACIO GENOMICA2
FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALLHEBRON2
FUNDACION CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS CARLOS III2
FUNDACION HOSPITAL LA FE2
FUNDACION INSTITUTO DE ESTUDIOS DE CIENCIAS DE LA SALUD DE CASTILLA Y LEON2
GABO:MI GESELLSCHAFT FUR ABLAUFORGANISATION:MILLIARIUM MBH & CO KG GAB O2
GMV SOLUCIONES GLOBALES INTERNET SAU2
GPOH GEMEINNUTZIGE2
GROUPE FRANCOPHONE DES MYELODYSPLASIES2
GSK VACCINES INSTITUTE FOR GLOBAL HEALTH2
HELMHOLTZZENTRUM FUER INFEKTIONSFORSCHUNG2
HELMHOLTZZENTRUM FUR INFEKTIONSFORSCHUNG2
ILLUMINA CAMBRIDGE2
IMAXIO2
INFRAFRONTIER2
INSTITUT CURIE2

Constancy:

Total number of partners: 762
Partner loyalty:
Frequent Partner: (> 2 projects): 319
Rare Partner: 443
Frequent / Rare Partner Ratio: 0.72

Project overview:

Start dateProjectacronymrolefundingpartners
2023-01-01Learning and modeling the molecular response of single cells to drug perturbations DeepCellparticipant2.497.2982
2022-09-01Biodiversity Genomics Europe BGEparticipant17.080.73833
2021-11-15Characterizing gene regulation in single cells through integration of scRNA-seq and scATAC-seq data with generic multi-modal prior information GReCScoordinator224.9341
2021-07-01Building a reproducible single-cell experimental workflow to capture tumour drug persistence PERSIST-SEQparticipant7.057.98016
2021-06-15Comparative modelling of organoids in the age of single-cell transcriptomics OrganoidAligncoordinator212.9341
2021-03-01European Network Linking Informatics and Genomics of Helper T cells in Tissues ENLIGHT-TENplusparticipant4.067.52615
2021-02-01Dietary shaping of the early life metabolome and its role in healthy lung and brain development DEFENDparticipant1.499.9522
2021-02-01Comparative transcriptomics of phylogenetically selected pathogenic treponemes cultivated in vitro under different conditions: First insight to the expression changes linked with genomic variants ComTransTrepcoordinator212.9341
2020-11-09Deciphering the developmental roots of childhood sarcoma cells – combining single cell sequencing technologies and machine learning CAtScoordinator224.9341
2020-10-01HEALTHCARE ALLIANCE FOR RESOURCEFUL MEDICINES OFFENSIVE AGAINST NEOPLASMS IN HEMATOLOGY – PLUS HARMONY PLUSparticipant6.715.62541
2020-01-01Human Gonad Developmental Cell Atlas HUGODECAparticipant4.822.19710
2020-01-01HUMAN UTERUS CELL ATLAS HUTERparticipant4.118.9437
2020-01-01Discovering the cellular landscape of the airways and the lung discovAIRparticipant4.958.68318
2018-05-01LIFE LAB - Connecting Communities with the UK's leading Biotechnology and Life Science Hub LIFE LABcoordinator158.5205
2017-01-01Towards enduring mouse resources and services advancing research into human health and disease INFRAFRONTIER2020participant4.955.87730
2017-01-01Optimizing a deployable high efficacy malaria vaccine OptiMalVaxparticipant20.050.44118
2017-01-01Development of Effective Vaccines against Multiple Lifecycle Stages of Plasmodium vivax malaria MultiViVaxparticipant5.058.9748
2017-01-01Healthcare Alliance for Resourceful Medicines Offensive against Neoplasms in HematologY - Sofia ref.: 116026 HARMONYparticipant20.200.00053
2016-01-01New players in human BAT differentiation and activation: a human PSC-derived BAT approach combined with state of the art genome engineering and –omics based methodologies StemBATcoordinator2.500.0002
2016-01-01Re(defining) CD4+ T Cell Identities One Cell at a Time ThDEFINEparticipant1.980.6852
2015-11-01European AIDS Vaccine Initiative 2020 EAVI2020participant22.948.02226
2015-10-01European Network linking informatics and genomics of helper T cells ENLIGHT-TENparticipant3.354.68511
2015-10-01Unravelling host intestine-parasite interactions that define immune responses to whipworms GUTWORMcoordinator183.4551
2015-08-01Massive Reverse Genomics to Decipher Gene Regulatory Grammar MRG-GRammarparticipant3.999.6617
2015-06-01Research Infrastructures for Phenotyping, Archiving and Distribution of Mouse Disease Models - Promoting International Cooperation and User Engagement to Enhance Biomedical Innovation IPAD-MDparticipant1.103.61411
2015-06-01MELanoma GENetics - understanding and biomarking the genetic and immunological determinants of melanoma survival MELGENparticipant3.988.3666
2015-01-01Computational and functional annotation of genomic elements during development of the model vertebrate zebrafish ZENCODEparticipant3.948.84411
2014-12-01COllaborative Management Platform for detection and Analyses of (Re-)emerging and foodborne outbreaks in Europe COMPAREparticipant20.817.77129
2014-07-01Identification of drug-resistance genes for the development of effective combined therapies for melanoma MELANOMA DRUG RESISTcoordinator221.6061
2014-05-01The Role of Protein N-Glycosylation in Bone and Energy Homeostasis SUGARYBONEcoordinator221.6061
2014-04-01Bridging the Evolution and Epidemiology of HIV in Europe BEEHIVEparticipant2.499.7393
2014-02-01Mechanisms and Treatment of Migraine and its Chronification EUROHEADPAINparticipant5.996.72613
2013-10-01Collaborative European NeuroTrauma Effectiveness Research in TBI CENTER-TBIparticipant29.998.90338
2013-06-01Testing and validation of bispecific antibody combinations targeting treatment-resistant cancer stem cells using organoid-based screening tools: a new drug discovery paradigm SUPPRESSTEMparticipant5.953.3195
2013-05-01Combination therapies for personalized cancer medicine COMBATCANCERparticipant14.580.5582
2013-05-01"THE LANDSCAPE AND FUNCTIONAL IMPACT OF TUMOUR-SPECIFIC GENOMIC INSERTIONS OF 1,000 CANCER GENOMES" CANCER INSERTOMEcoordinator221.6061
2013-02-01BBMRI - Large Prospective Cohorts BBMRI-LPCparticipant8.000.00030
2013-01-01Development of mouse mutant resources for functional analyses of human diseases - Enhancing the translation of research into innovation INFRAFRONTIER-I3participant9.900.00023
2012-06-01Sequencing population isolates to find complex trait loci SEPIparticipant1.477.9321
2012-04-15Gene Discovery in Melanoma Progression and Therapeutic Resistance Melanoma Genescoordinator209.5932
2012-01-01Genetic and physiological basis of thinness STILTSparticipant1.500.0002
2011-11-01Genetic studies of pre-eclampsia in Central Asian and European populations InterPregGenparticipant5.961.64812
2011-10-01Coordinating the cooperation of the ESFRI project Infrafrontier with the International Phenotyping Consortium (IMPC) InfraCoMPparticipant779.9979
2011-10-01A BLUEPRINT of Haematopoietic Epigenomes BLUEPRINTparticipant29.996.66445
2011-08-08The molecular regulation of T helper cell subtype plasticity ThPLASTcoordinator211.0932
2011-07-01Dissecting cGMP- and calcium-dependent signalling pathways that control gliding of a malaria zoite Plasmodium motilitycoordinator179.6031
2011-05-01IT Future of Medicine ITFoMparticipant1.480.00025
2011-05-01Human Brain Project HBPparticipant1.414.38813
2011-02-01European Sequencing and Genotyping Infrastructure ESGIparticipant9.499.99911
2011-01-01Predicting individual response and resistance to VEGFR/mTOR pathway therapeutic intervention using biomarkers discovered through tumour functional genomics PREDICTparticipant5.841.00914

overview shows latest 50 from 64 projects (2010-01-01 - 2025-12-31)
A full list of projects can be found here:

Alias institution names:

  • GENOME RESEARCH
  • GENOME RESEARCH LIMITED